A CRISPR-Cas12a-Based Diagnostic Method for Japanese Encephalitis Virus Genotypes I, III, and V

Biosensors (Basel). 2023 Jul 28;13(8):769. doi: 10.3390/bios13080769.

Abstract

The Japanese encephalitis virus (JEV) is prevalent in Asian countries, including Korea, Japan, China, Vietnam, and India. JEV is transmitted to humans by Culex mosquitoes. Despite extensive research efforts, no approved antiviral agents are currently available, although JE can be prevented by vaccination. DNA endonuclease-targeted CRISPR trans reporter (DETECTR) is a newly emerging CRISPR-Cas12a-based molecular diagnostic method combined with isothermal nucleic acid amplification. In this study, DETECTR with reverse transcription-recombinase polymerase amplification (RT-RPA) was effectively utilized for JEV diagnosis and detected down to 10 RNA copies for JEV genotype I (GI) and 1 × 102 copies for both GIII and GV, achieving similar sensitivity to RT-PCR while displaying no cross-reaction with other viruses. A one-tube, one-temperature format of DETECTR was further developed, and its efficiency compared with that of conventional DETECTR.

Keywords: CRISPR-Cas12a; DETECTR; Japanese encephalitis virus; diagnosis.

MeSH terms

  • Animals
  • Antiviral Agents
  • CRISPR-Cas Systems
  • China
  • Encephalitis Virus, Japanese* / genetics
  • Genotype
  • Humans

Substances

  • Antiviral Agents